Autolus Therapeutics plc
AUTL
$2.13
-$0.10-4.28%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -21.35% | -30.30% | 16.81% | 2.65% | -7.62% |
| Total Depreciation and Amortization | 25.03% | 27.19% | 24.90% | 26.33% | 26.50% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 246.40% | 52.11% | -73.96% | -102.86% | -77.19% |
| Change in Net Operating Assets | -84.03% | -119.78% | -1,888.94% | -333.66% | -306,577.78% |
| Cash from Operations | -13.26% | -37.47% | -31.58% | -67.94% | -67.96% |
| Capital Expenditure | 54.72% | 13.73% | -149.52% | -732.86% | -277.17% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 177.31% | 147.65% | -- | -- | -- |
| Cash from Investing | 169.26% | 140.16% | -2,405.42% | -8,104.41% | -5,643.52% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -99.97% | -99.94% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -123.03% | -111.13% | 205.94% | 225.70% | 153.61% |
| Cash from Financing | -122.77% | -100.74% | -95.09% | -94.74% | -94.99% |
| Foreign Exchange rate Adjustments | -83.67% | 2,505.75% | -168.15% | 1,145.25% | -31.25% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 105.31% | -968.26% | -242.13% | -245.72% | -259.13% |